Evaluation of Microbial Recovery from Raw Materials for Pharmaceutical Use by Eissa, Mostafa & Mahmoud, Ahmed
J.Food Pharm.Sci. 4 (2016) 6-11  
 
 
Research Article 
Evaluation of Microbial Recovery from Raw Materials for Pharmaceutical Use 
 
Mostafa Eissa, Ahmed Mahmoud 
 
Quality Control, Microbiology Section, HIKMA Pharma. 
 
 
ARTICLE INFO 
 
ABSTRACT 
 
Received 10/03/2015 
Received in revised form 
25/03/2015 
Accepted 25/04/2015 
Available online 01/5/2015 
 
 
E-mail address: 
mostafaessameissa@ 
yahoo.com  
 Microbiological quality of raw materials used in pharmaceutical manufacturing 
is critical attribute that affects the bioburden level of the final product. If the 
preliminary treatment for the microbiological analysis of the material is not  
suitable to recover actual microbial content, false estimation of microbial 
presence and/or count in raw materials may impact final product quality and 
safety. Accordingly a survey study was conducted on 12 selected materials that  
are used extensively in the manufacturing facility in order find suitable  
technique to recover low-level inoculums of standard strains. The basic 
processing and/or neutralization technique was dilution alone or in 
combination with chemical neutralization or less frequently filtration. Dill oil  
was the only raw material required combination of dilution and chemical 
neutralization for both of microbial enumeration and detection while this 
combination was necessary only in enumeration for Cetostearyl Alcohol. 
Although dilution method may be adopted alone for Sorbitol solution 70% yet 
filtration was done in combination to facilitate the visualization of commonly 
found ye ast  contaminant  from the suppliers of the raw materials. Balsam Peru 
required the highest dilution among the tested materials for enumeration. The 
applied neutralization techniques were effective in detecting low level 
contamination in raw materials.  
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1.   Introduction 
Microbial contamination of drug products causes 
pharmaceutical companies great financial loss. Analysis 
of FDA product recall data for 134 non-sterile 
pharmaceutical products from 1998 to September 2006 
demonstrated that 48% of recalls were due to 
contamination by Burkholderia cepacia, Pseudomonas 
spp., or Ralstonia picketti, while yeast and mold 
contamination were found in 23% of recalls. Gram -
negative bacteria accounted for 60% of recalls, but only 
4% were associated with Gram-positive bacteria. Of the 
193 recalls of sterile products, 78% were due to the lack 
of sterility assurance and 7% for yeast and mold 
contamination. For sterile products, Gram-negative 
bacteria accounted for 6% of recalls, with only 1% due to 
Gram-positive bacteria (Jimenez, 2007).  
The majority of the contaminants of non sterile 
pharmaceutical products and ingredients are bacteria, 
yeasts, and filamentous fungi (molds). These organisms 
have a wide range of nutritive requirements and 
environmental conditions suitable for their proliferation. 
Many of the ingredients used in pharmaceutical 
formulations can become substrates for 
microorganisms (Clontz, 2008).  
Microbial contamination of raw materials used to 
manufacture dry formulations (e.g. tablets) is often 
reduced by drug manufacturing processes such as 
granule drying and tablet compaction. The amount of 
bioburden reduction is directly dependent on the 
process temperature, chemical properties of the drug 
formulation, tablet compression pressure, and 
metabolic properties of the contaminating microbes. 
For example, bacterial spores are less susceptible to the 
harsh conditions encountered during tablet 
processing and the survival of Bacillus subtilis 
spores found in raw materials has been studied and 
documented (Marshall et al., 1998). Although dry 
formulations are less susceptible to microbial 
contamination, the spoilage of solid dosage form 
products by   vegetative   organisms   has   also     been  
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Table (1): List of non-sterile pharmaceutical products subjected to neutralization method validation.  
 
Raw Material  Synonyms Chemical Nature Pharmaceutical Use 
Avicel PH 102 
Microcrystalline Cellulose 
(INCI*), MCC, cellulose gel. 
Carbohydrate of alpha-cellulose (purified 
and partially depolymerized cellulose 
made by acid hydrolysis of wood pulp). 
Tablet binder. 
Balsam Peru 
Myroxylon pereirae (INCI*), 
China oil, Black, Indian, 
Peruvian, Surinam and 
Honduras balsam. 
Benzoic alcohol, Benzyl benzoate and 
other benzoates, Benzyl acetate, Benzoic 
acid, Benzyl cinnamate, Benzaldehyde, 
benzyl salicylate, Cinnamic acid, Cinnamyl 
cinnamate, Cinnamic alcohol, Cinnamic 
aldehyde, Citrus peel, Coniferyl alcohols, 
Coumarin, Eugenol, Farnesol, Isoeugenol, 
Methylcinnamate, Nerolidol, Vanillin and 
resinous substances. 
Possesses healing properties. It has 
aromatic and fixative (i.e., delays 
evaporation) properties, and mild 
antiseptic, antifungal, and antiparasitic 
attributes.[13] 
Cetostearyl 
Alcohol 
Cetearyl alcohol, Cetylstearyl 
alcohol, Cetyl/stearyl alcohol. 
Mixture of fatty alcohols, consisting 
predominantly of Cetyl and Stearyl 
alcohols and is classified as a fatty 
alcohol. 
Emulsion stabilizer, opacifying agent, 
and foam boosting surfactant and an 
aqueous and nonaqueous viscosity-
increasing agent. It imparts an 
emollient feel to the skin and used in 
water-in-oil emulsions, oil-in-water 
emulsions, 
Cetyl Palmitate 
Spermaceti, Palmatic acid n-
hexadecyl ester, Palmitic acid 
n-hexadecyl ester, Palmitic acid 
palmityl ester, Palmitic acid 
hexadecyl ester, Palmitic acid 
cetyl ester, Palmityl palmitate, 
n-hexadecylpalmitat. 
Ester derived from palmitic acid and cetyl 
alcohol. 
Emulsifying and stiffening agent. 
Dill Oil 
Dillweed, American dill weed 
oil, Aneth oil, Anethum 
graveolens oil, Dill fruit oil, Dill 
oil Indian, Dill seed oil Indian, 
Dill seed oil. 
Carvone (30 to 40%), Limonene (30 to 
40%), Phellandrene (10 to 20%) and other 
monoterpenes. 
Abortifacient, Antifungal, Aromatic, 
Carminative, Galactagogue, Insect 
repellents, Psychedelic and Stomachic. 
Glycerol Glycerin, Glycol alcohol. 1,2,3-propanetriol, Polyol (sugar alcohol). 
Used as a means of improving 
smoothness, lubrication and as 
humectant. It is found in allergen 
immunotherapies, cough syrups, elixirs 
and expectorants, and mouthwashes 
Kaolin Light 
China clay, Bolus alba, 
Porcelain clay, White bole, 
Argilla.  
Hydrated aluminum silicate. 
Used internally to control diarrhea. 
Kaolin has also been used topically as 
an emollient and drying agent. It has 
been used as protectant for temporary 
relief of anorectal itching and diaper 
rash. 
Maize Starch  Corn flour, Corn Starch. 
Amylose (20 to 25%) and Amylopectin (75 
to 80%). 
Disintegrant and binder. 
Sodium 
Croscarmellose 
Cross-linked Sodium 
Carboxymethylcellulose, 
Sodium CMC.  
Cellulose Derivative. Disintegrant. 
Sorbitan 
Monostearate 
Synthetic wax, Span 60, D-
Glucitol, Anhydro- 
monooctadecanoate, 
Anhydrosorbitol stearate, 
Sorbitan monooctadecanoate. 
Ester of sorbitan (a sorbitol derivative) 
and stearic acid. 
Emulsifying agent with dispersing and 
wetting properties. Used in 
hemorrhoid creams and creams to 
treat dry skin.  
Sorbitol 70% D-Glucitol, D-Sorbol, Sorbit. Sugar alcohol. Sweetener or 7umectants.  
Xanthan Gum 
Xantham, xanthan, Keltrol f, 
Rhodopol 23, Glucomannan, 
Xanthate gum. 
Polysaccharide composed of 
pentasaccharide repeat units, comprising 
glucose, mannose, and glucuronic acid in 
the molar ratio 2.0:2.0:1.0.  
Thickening, stabilizing, suspending and 
Controlled release agent. 
 
*= International Nomenclature of Cosmetic Ingredients. 
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observed, especially in tropical and humid climates. As 
reported in the Pakistan Journal of Scientific and 
Industrial Research (Cundell, 2002), various types of 
tablets, both coated and noncoated, were found to be 
contaminated with bacteria such as Klebsiella aerogenes , 
Bacillus cereus , Pseudomonas aeruginosa, and 
Staphylococcus  aureus. Fungi were also isolated from 
the samples tested and those included Penicillium 
chrysogenum, Aspergillus flavus , Candida albicans, and 
Saccharomyces spp. The total bacterial count in the 
contaminated products ranged from 2.0 × 103 to 8 × 107 
colony forming units (CFU) per mL of sample 
preparation, and the total fungal count  ranged from 20 
to 1.4 × 102 CFU per mL of sample preparation. This 
article indicated that the contaminating microbes were 
capable of proliferating in the product by utilizing the 
chemicals in the drug formulations as sole carbon and 
energy sources.  
The current work was aimed to study the 
recovery of low level of microbial contamination from 
the selected raw materials that are commonly used in 
the manufacturing of drug products and those with 
antimicrobial properties and to establish treatment 
methods and processing techniques for the selected 
raw materials based on each nature and situation as a 
part of risk assessment study in pharmaceutical 
industry. 
 
2.   Material and Methods 
Standard strains and neutralizing broth (NB) 
were prepared as described by Eissa et al., 2014 with 
modification of adding Lecithin 7.0 g/L to NB. Tryptone 
Soya Broth (TSB) was supplemented with Lecithin and 
Tween (80 5.0 and 40.0 g/L respectively). Tests for 
microbial enumeration and detection of specific 
pathogens were done according to USP <61>, 2014 and 
USP <62>, 2014. List of tested raw  materials, their 
chemical composition and their use is listed in table (1). 
Both liquid and agar media were growth promotionally 
tested according to USP <61>, 2014. Method of sample 
treatment  was  modified  when  conventional technique  
yield results that  are unsatisfactory for one or more of 
the tested microorganisms in either enumeration or 
specific microbes detection. All  test procedures were 
conducted in biological safety cabinet (BSC). Control 
media were incubated along with test media to ensure 
sterility. All statistical analysis was performed using 
GraphPad Prism version 6.01 for Windows. Any 
interpretation or complex calculation was performed 
using Microsoft Excel 2007. Moreover environmental 
monitoring (EM) samples from surfaces and air were 
taken with every campaign test performed in BSC to 
ensure appropriate cleaning, disinfection and aseptic 
behavior under laminar air flow (LAF) conditions. 
Bacterial visualization was facilitated using colorless 
Triphenyltetrazolium Chloride (TTC) dye which turns red 
by viable cells. Cultures purity and identity were 
confirmed by isolation and identification (Eissa, 2014; 
Estridge et al ., 2000). Interpretation of microbial 
recovery was based on 0.3 Log10 variability as described 
by Eissa and Nouby, 2014. 
 
3.   Results and Discussion 
 All prepared media passed the growth 
promotion test of culture media. Initial assessments of 
bioburden quality of the tested raw materials –using 
conventional methods- revealed that the tested 
products were clean microbiologically. Chemical 
neutralization method was found to be non toxic and 
microbial recovery was ≥70% from the viability control 
group. This finding is supported by similar finding of 
Eissa et al., 2014 for the chemical neutralizers used. 
Negative controls and EM samples showed no growth 
indicating appropriately sterilized media and aseptic 
handling. Results in table (2), (3) and (4) – all passed the 
method suitability test - were obtained after applying 
suitable treatment for the samples using dilution, 
filtration and chemical neutralization methods as 
indicated in table (5). Sorbitol 70% solution has previous 
history of out of specification (OOS) results from some 
suppliers in total yeast mold count (TYMC) due to 
contamination with slow growing white yeast that 
appeared after 7 days using pour plate technique. This 
necessitates the modification illustrated in table (4) as 
filtration allowed for earlier detection of 
microorganisms than direct plating. Balsam Peru, 
Cetosearyl Alcohol, Dill Oil and to much lesser extent 
Glycerol possessed inhibitory effect on low level 
inoculums when prepared and homogenized to 1:10 w/v 
dilution in either media or diluent. This is an area that 
needs more investigation. Block 1991 demonstrated that 
many organic alcohols, acids and esters possess 
antimicrobial properties. However, Avicel PH102, 
Sodium Croscarmellose and Xanthan Gum (hydrophilic 
macromolecules) formed solid gels and undispersed 
limps before attaining 1:10 ratio in saline or TSB. This 
necessitates performing higher dilution to achieve 
reliable sample homogeneity, easier sample processing 
for further testing and maintain appreciable water 
activity for microbial survival especially for Gram -
negative bacteria and attenuated microorganisms. This 
is not  strange in view of that Clontz 2008 discussed 
similarly that Syrups containing a high concentration of 
sugar (approximately 85%) resist bacterial growth owing 
to the exosmotic effect on microorganisms. Marshall 
1998 and Cundell et al ., 2002 demonstrated that 
although the microbial limit tests call for the use of the 
Sabouraud Dextrose Agar (SDA) for the recovery of 
fungi, studies performed over the years have 
demonstrated that all-purpose media are capable of 
recovering a wide range of bacteria, yeasts, and       
molds. This was shown in the study by using both 
Candida albicans and Apergillus niger with SDA (20 - 25°C) 
and the all purpose media Tryptone Soya Agar (TSA) (30 
- 35°C) in Figure (1). Actually although C. albicans passed 
the test, it showed relatively lower recovery if compared 
with other standard strains. Two-Way ANOVA         
without replication was used to analyze transformed 
microbial recovery from the tested materials.                     
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Table (2): Screening for the neutralization procedures applied for insurance of non -toxicity of the method applied in 
microbiological testing against tested microorganisms.  
 
Raw Material  
Ratio of Microbial Recovery 
Staphylococcus 
aureus 
Bacillus 
subtilis 
Pseudomonas 
aeruginosa  
Candida albicans Aspergillus niger  
30-35°C 30-35°C 30-35°C 20-25°C 30-35°C 20-25°C 30-35°C 
Avicel PH 102 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Balsam Peru 0.027 0.032 -0.009 0.018 -0.127 0.000 0.000 
Cetostearyl Alcohol  0.004 0.114 0.000 0.000 0.036 0.060 -0.049 
Cetyl Palmitate  0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Dill Oil  -0.025 0.004 0.000 -0.090 -0.061 -0.179 -0.173 
Glycerol  0.000 -0.009 0.066 0.000 0.000 0.000 0.000 
Kaolin Light  0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Maize Starch 0.022 0.036 0.114 0.000 0.000 0.000 0.000 
Sodium Croscarmellose  0.000 0.000 0.000 -0.100 0.000 0.000 0.000 
Sorbitan Monostearate  0.004 0.114 0.000 0.000 0.036 0.097 -0.049 
Sorbitol 70%  0.000 0.000 0.000 -0.049 0.161 0.102 0.194 
Xanthan Gum  0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 
Table (3): Screening for enumeration of the microbial recovery from raw materials that are used in pharmaceutical 
products manufacturing after applying appropriate neutralization procedures. 
 
Raw Material  
Ratio of Microbial Recovery 
Staphylococcus 
aureus 
Bacillus 
subtilis 
Pseudomonas 
aeruginosa  
Candida albicans Aspergillus niger  
30-35°C 30-35°C 30-35°C 20-25°C 30-35°C 20-25°C 30-35°C 
Avicel PH 102 -0.072 0.071  0.131 0.244 0.174 -0.017 -0.076 
Balsam Peru -0.057 0.018 0.027 -0.033 0.000 0.102 0.000 
Cetostearyl Alcohol  0.194 -0.130 0.066 0.194 0.066 0.292 -0.127 
Cetyl Palmitate  -0.121  -0.041  -0.072 0.076 0.301  0.131 -0.009 
Dill Oil  -0.037 -0.093 0.032 0.108 -0.045 -0.045 0.060 
Glycerol  -0.134 0.018 0.022 -0.025 0.143 0.066 -0.114 
Kaolin Light  -0.004 0.174 -0.152 0.268 0.125 -0.230 -0.114 
Maize Starch -0.083 0.125 0.009 0.027 0.276 0.114 -0.212 
Sodium Croscarmellose  -0.029 0.018 -0.004 0.056 0.081  -0.097 0.000 
Sorbitan Monostearate  -0.053 -0.01 3 0.004 0.102 -0.01 3 0.155 -0.173 
Sorbitol 70%  0.022 0.013 -0.01 3 -0.029 -0.090 0.237 0.022 
Xanthan Gum  -0.057 0.004 -0.017 0.222 -0.086 0.155 -0.241  
 
Table (4): Survey study for specific microorganisms detection from raw materials that are used in pharmaceutical 
products manufacturing after applying the neutralization procedures.  
 
 Raw Material  
Detection of Specific microorganisms 
Staphylococcus 
aureus 
Salmonella 
enterica 
Pseudomonas 
aeruginosa 
Escherichia 
coli  
Candida 
albicans 
Bile Tolerant Gram-
negative Bacteria 
Avicel PH 102 + + + + + + 
Balsam Peru + + + + + + 
Cetostearyl Alcohol  + + + + + + 
Cetyl Palmitate  + + + + + + 
Dill Oil  + + + + + + 
Glycerol  + + + + + + 
Kaolin Light  + + + + + + 
Maize Starch + + + + + + 
Sodium Croscarmellose  + + + + + + 
Sorbitan Monostearate  + + + + + + 
Sorbitol 70%  + + + + + + 
Xanthan Gum  + + + + + + 
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Data analysis  showed that  raw materials (each  with          
its special treatment method) did not possess   
significant     difference    from   eac h other (raw factor).  
On the other hand, there was significant difference 
between microorganisms groups (column factor). 
Column Factor accounts for 26.63% of the total variance 
with F = 4.29, DFn=6, DFd=66 and the P value = 0.0010. 
Row Factor accounts for 5.06% of the total variance with 
F = 0.44,  DFn=11, DFd=66 and the P value = 0.9294. 
According to USP Chapter <1227> 2014, Validation of 
Microbial Recovery from Pharmacopeial Articles as the 
number of CFUs decreases the error as percent of the 
mean increases so inoculums controls of 22 CFUs or 
more but less than 100 CFUs were used in order to 
minimize errors in enumeration i.e. error as percent of 
mean plate count is less than 21%.  
 
4.   Conclusion 
The established neutralization techniques for the 
tested samples were effective in recovering low level of 
aerobic mesophilic microbial contamination of 
representative microorganisms from bacteria and fungi. 
These results could be useful in applying bracketing or 
matrixing for  materials. For  example, the treatment 
method applied for Avicel or Starch could be applied to 
other types or varieties of them.  
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using GraphPad Prism v6.01 for Windows) APV= Acceptable Plating Variability. 
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